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Introduction
A healthy baby and a healthy mother are valued hopes and
dreams of families of all cultural heritages. National health
goals in many countries around the world prioritize infant
andmaternalmortalityandmorbidity.IntheUnitedStates,as
in many other industrialized countries, pregnancy outcomes
andmaternalandinfanthealthindicatorshaveimproveddra-
matically. At the turn of the 20th century, 7.28 women and
96 infants died for every 1,000 babies born alive [1]. By the
end of the year 2000, the maternal mortality rate had de-
creased to less than 0.08 and infant mortality had decreased
to less than 7 deaths per 1,000 live births [2]. These changes
were characterized as one of the ten “great public health
achievements” of the 20th century [3]. Much of this progress
can be attributed to changes in social and living conditions
as well as the development and implementation of effective
medical interventions. Despite this progress, during the last
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two decades of the 20th century, even in the presence of
signiﬁcant breakthroughs in medical technology and its ap-
plication, improvements in maternal and infant pregnancy
ouctomes slowed down signiﬁcantly, and in some cases, out-
comes deteriorated. For example, from 1960 to 1980, the
maternal mortality rate decreased from 32.1 to 9.4 deaths
per 100,000 live births, a decrease of 70.7%. From 1980
to 2000, the maternal mortality rate decreased only 12.8%,
from9.4to8.2(Figure1)[2].Atthesametime,from1980to
2000, the proportion of babies born preterm, very preterm,
low birth weight, and very low birth weight increased by
26%, 8.2%, 14.7% and 25.9%, respectively (Figure 2)[ 4].
However, unlike other maternal and infant health indicators,
from 1980 to 2000 the infant mortality rate continued to de-
crease almost at a similar pace as that from 1960 to 1980,
dropping by 45.2% from 12.6 to 6.9 infant deaths per 1,000
live births, compared with a drop of 51.5% from 26.0 to 12.6
per 1,000 live births for 1960 to 1980 (Figure 1)[ 2]. Fi-
nally, it is estimated that the proportion of babies born in the
United States who have a serious or major structural defect
that can have adverse effects on their health or development
continues to be about 3% [5].
Associatedwiththisslowingrateofimprovement(and,in
some cases, deterioration) in pregnancy outcomes and ma-
ternal and infant health indicators is a shift in the leading
causes of infant mortality. In 1960, maternal complications
ofpregnancy(includingcomplicationsofplacenta,cord,and
the membranes) did not appear on the list of the 10 leading
causes of infant mortality [1]. By 1980, maternal complica-
tions of pregnancy became the ﬁfth leading cause of infant
mortality,andthethirdleadingcauseofinfantdeathin2002,
after congenital anomalies and low birth weight/preterm de-
livery[6,7].In2002,congenitalanomalies,lowbirthweight,
preterm delivery, and maternal complications of pregnancy
accounted for 46.4% of all infant deaths in the United States
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Fig. 1 Maternal and infant
mortality rates, United States,
1960–2002
(12,996infantdeaths)(Figure3)[7].Althoughsomeofthese
infant deaths might have been prevented through interven-
tions targeted at improving the health of mothers and modi-
fyingbehaviorscontributingtoadversepregnancyoutcomes,
poormaternalhealth,behaviorscontributingtoadversepreg-
nancy outcomes, and maternal complications of pregnancy
continuetobeprevalent.Forexample,28.6%ofwomenwho
gave birth between 1993 and 1997 were reported to have
an obstetric complication, 4.1% had a preexisting medical
condition, and 43.0% experienced some form of maternal
morbidity(i.e.,anobstetriccomplication,apreexistingmed-
ical condition, a cesarean section, or any combination of the
threetypesofmorbidity)[8].In2002,26.1%ofalldeliveries
were performed using cesarean section, presumably because
of maternal or infant complications [8].
Early prenatal care is too late
One of the reasons that progress in improving pregnancy
outcomes has slowed down, and in some cases reversed di-
rection, is that we have failed to intervene before pregnancy
to detect, manage, modify, and control maternal behaviors,
health conditions, and risk factors that contribute to adverse
maternal and infant outcomes. Although we know many in-
terventions that, if delivered before pregnancy, could im-
prove pregnancy outcomes, we have failed to make those
services and interventions available to couples and women
in need. Women of childbearing age suffer from a vari-
ety of chronic conditions that could potentially contribute
to adverse pregnancy outcomes. For example, in 2002, the
U.S. Department of Health and Human Services reported
that 6.1% of women of reproductive age have asthma, 5%
are obese, 3.4% have cardiac disease, 3.0% are hyperten-
sive, 9.3% are diabetic, and 1.4% have thyroid disorder [9].
Moreover, a substantial proportion of women continue to
enter pregnancy with risks proven to contribute to adverse
pregnancy outcomes: in 2002, 11.4% of pregnant women
smoked during pregnancy, a risk factor for low birth weight
[4]; at the same time, 10.1% of pregnant women and 54.9%
of women at risk of getting pregnant consumed alcohol, a
risk factor for fetal alcohol syndrome [10]. Finally, using
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Fig. 3 Leading causes of infant mortality, United States, 1960, 1980, and 2002. ∗IMR = Infant Mortality Rate
the Perinatal Periods of Risk approach, researchers in three
cities (New York City; Tulsa, Oklahoma; and Kansas City,
Missouri)concludedthatracialandethnicdisparitiesinfeto-
infant mortality were largely related to maternal health, and,
interventions to reduce feto-infant mortality should include
preconception care and improvements in women’s health
[11–13].
The prenatal care “revolution” of the 1980s resulted in an
increase in the proportion of women receiving early prenatal
care (deﬁned as prenatal care begun in the ﬁrst trimester)
[2]. After decreasing from 76.3% in 1980 to 75.8% in 1990,
the proportion of women receiving early prenatal care in-
creased to 83.2% in 2000 [2]. However, for many women,
“early prenatal care is too late” [14]. By the time a preg-
nant woman makes it to her ﬁrst early prenatal visit, most
fetal organs are already been formed, and many interven-
tions to prevent birth defects or adverse maternal and infant
outcomes come too late to have any effect. As a result, many
national organizations now recommend routine preconcep-
tion care. For example, the March of Dimes recommends
that “as the key physician/primary care provider, the obste-
trician/gynecologists must take advantage of every health
encounter to provide preconception care and risk reduction
beforeandbetweenconceptions—thetimewhenitreallycan
make a difference” [14]. The American Academy of Pedi-
atrics (AAP) and the American College of Obstetricians and
Gynecologists (ACOG) recommend that “all health encoun-
ters during a woman’s reproductive years, particularly those
that are a part of preconception care, should include coun-
seling on appropriate medical care and behavior to optimize
pregnancy outcomes” [15].
Preconception interventions work
Interventions designed to lower preconception risks are
known collectively as preconception care. These interven-
tions are characterized by the need to start—and sometimes
complete—a designated intervention before conception oc-
curs. To simplify matters, ACOG and AAP have grouped
the main components of preconception care under four cat-
egories of interventions: maternal assessment (e.g., family
history, behaviors, obstetric history, general physical exam);
vaccinations (e.g., rubella, varicella and hepatitis B); screen-
ing (e.g., HIV, STD, genetic disorders); and counseling
(e.g., folic acid consumption, smoking and alcohol cessa-
tion, weight management) [15]. Many of these interventions
are currently available to women and, when indicated, to
couples; however, they are not systematically delivered. A
comprehensive review of the literature identiﬁed a long list
of risk factors suggested to be included in comprehensive
preconception care (Table 1). The strength of evidence sup-
porting the efﬁcacy of the various components of precon-
ception care varies greatly [16]. Clinical practice guidelines
(CPGs) have been developed for reducing the risk related to
some of these factors. We identiﬁed 14 conditions for which
CPGsexistandforwhichthereisscientiﬁcevidence demon-
strating effectiveness in improving pregnancy outcomes
(Table 2)[ 17–74].
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Table 1 Risk factors (by
Category) identiﬁed in the
literature as needing attention
during the preconception period
1 Chronic diseases: Diabetes; heart disease; high blood pressure; thyroid disease; asthma; anemia; kidney
disease; metabolic and hematological disorders; depression and other mental disorders; autoimmune
disease; and physical disability (access)
2 Infectious diseases: Vaccine-preventable diseases (rubella, hepatitis B, varicella, inﬂuenza, and
tetanus); HIV/AIDS; syphilis, chlamydia, and other sexually transmitted diseases; periodontal disease;
toxoplasmosis, and cytomegalic inclusion virus
3 Reproductive concerns: Unplanned pregnancies; contraception; infertility; adverse past pregnancy
outcomes (preterm delivery, birth defects, fetal/infant death, maternal complications)
4 Genetic/inherited conditions: Sickle cell anemia; thalassemia; Tay-Sachs disease; fragile X syndrome;
Down syndrome; cystic ﬁbrosis; muscular dystrophy; hearing and vision loss associated with genetic
predisposition
5 Medications and medical treatment: Prescription medications contraindicated in pregnant women
(FDA’s Category X Drugs, 117 products in 2001 PDR, antiepileptic drugs, oral anticoagulants for
maternal clotting disorders, and Accutane); diagnostic radiation exposures
6 Personal behaviors and exposures: Smoking; alcohol consumption; illicit drug use;
overweight/underweight; folic acid supplement use; domestic violence; eating disorders; exposure to
infections; exposures to chemicals and other environmental toxins; consumption of over-the-counter
medications; hyperthermia (e.g., from sauna use)
Note. This list is not exhaustive
However, the best evidence for the effectiveness of spe-
ciﬁc components of preconception care is seen when the
focus was on a single intervention and often not in the con-
text of improving pregnancy outcomes. For example, effec-
tiveness documented by the U.S. Preventive Services Task
Force for interventions related to smoking, alcohol misuse,
and obesity are based on studies of interventions delivered
in primary care settings that was not complicated by the ad-
ditional delivery of other components of preconception care
[56, 61, 66]. One study reported the effectiveness of com-
prehensive preconception care but inferences for the United
Statesarelimitedbecausethesettingofinterventiondelivery
was in Hungary [75].
Priorities for preconception care and preconception
health
The immediate priority is to ensure that evidence-based pre-
conceptioninterventionsareimplementedtofurtherimprove
infantandmaternalpregnancyoutcomes.Manynationalpro-
fessional organizations have developed and published CPGs
for speciﬁc components of preconception care. For example,
the American Diabetes Association developed CPGs to be
started before pregnancy for women with preconception di-
abetes [28]. The American Association of Clinical Endocri-
nologists has developed preconception CPGs for women
with hypothyroidism [34]. CPGs have also been developed
for women being treated with teratogenic medications to
guide the transition to safer medications. CPGs for women
using antiepileptic drugs or oral anticoagulants have been
developed by the American Academy of Neurology [50],
the American Heart Association, and the American College
of Cardiologists, respectively [44, 46]. Guidelines, recom-
mendations, and strategies for reducing alcohol misuse and
prevention of fetal alcohol syndrome have been developed
and published by the U.S. Public Health Service, U.S. Pre-
ventive Service Taskforce, ACOG, and the National Task-
force on Fetal Alcohol Syndrome and Fetal Alcohol Effects
[55–59].
However, moving forward towards more universal pre-
conception care is not without its challenges. There is no
national policy, nor do standard tools exist, for the deliv-
ery of these services. Some have suggested that challenges
could be overcome by promoting preconception health to all
women of reproductive age at each and every encounter with
the health care system. The generally recommended mech-
anisms would include risk assessment (screening), health
promotion (education and counseling), and intervention or
referral. However, the existing recommendations to provide
these three essential components have not been translated
into practical tools for action and decision-making in the
clinical setting. Stated another way, primary care providers
do not have the tools they need to implement what is known
to work for improving preconception health.
Challenges and opportunities
Whereas clinical practice and the promotion of preconcep-
tion care services could potentially be shaped by guidelines,
widespread adoption of the guidelines requires a more active
approach [76, 77]. The literature on diffusion of innovation
and translation of research into practice clearly indicates
that changing primary care providers’ knowledge, attitudes,
and practices requires multiple steps including consolida-
tion and distillation of guidelines, active organizational sup-
port, clinically relevant decision tools, use of quality im-
provementtechniques,andperformancemonitoring[78,79].
A growing body of research indicates that providers are
more likely to engage in evidence-based practices following
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Table 2 Selected
preconception risk factors for
adverse pregnancy outcomes for
which clinical practice
guidelines have been developed
• Folic acid. Daily use of vitamin supplements containing folic acid has been demonstrated to reduce the
occurrence of neural tube defects by two thirds [17–24]
• Rubella seronegativity. Rubella vaccination provides protective seropositivity and prevents the
occurrence of congenital rubella syndrome [25–27]
• Diabetes (preconception). The three-fold increase in the prevalence of birth defects among infants of
women with type 1 and type 2 diabetes is substantially reduced through proper management of diabetes
[28–31]
• Hypothyroidism. The dosages of LevothyroxineTM required for treatment of hypothyroidism increases
in early pregnancy. LevothyroxineTM dosage needs to be adjusted for proper neurologic development
[32–34]
• HIV/AIDS. If HIV infection is identiﬁed before conception, timely treatment can be administered and
women (or couples) can be given additional information that can inﬂuence the timing of the onset of
pregnancy [35–41]
• Maternal phenylketonurea (PKU). Women diagnosed with PKU as infants have infants with mental
retardation. However, this adverse outcome can be prevented when mothers adhere to a low
phenylalanine diet before conception and continue it throughout their pregnancy [42, 43]
• Oral anticoagulant. Warfarin, which is used for the control of blood clotting, has been demonstrated to
be a teratogen. To avoid exposure to warfarin during early pregnancy, medications can be changed to a
nonteratogenic anticoagulant before the onset of pregnancy [15, 44–46]
• Anti-epileptic drugs. Certain anti-epileptic drugs are known as teratogens. Before conception, women
who are on a regimen of these drugs and who are contemplating pregnancy should be prescribed a
lower dosage of these drugs [15, 47–51]
• Isotretinoins (Accutane r ): Use of isotretinoins in pregnancy to treat acne results in miscarriage and
birth defects. Effective pregnancy prevention should be implemented to avoid unintended pregnancies
among women with childbearing potential who use this medication [15, 52–54]
• Smoking. Preterm birth, low birthweight, and other adverse perinatal outcomes associated with maternal
smoking in pregnancy can be prevented if women stop smoking during early pregnancy. Because only
20% of women successfully control tobacco dependence during pregnancy, cessation of smoking is
recommended before pregnancy [55–58]
• Alcohol misuse. No time during pregnancy is safe to drink alcohol, and harm can occur early, before a
woman has realized that she is or might be pregnant. Fetal alcohol syndrome and other alcohol-related
birth defects can be prevented if women cease intake of alcohol before conception [59–64]
• Obesity. Adverse perinatal outcomes associated with maternal obesity include neural tube defects,
preterm delivery, diabetes, cesarean section, and hypertensive and thromboembolic disease. Weight loss
before pregnancy reduces these risks [15, 65–69]
• STD. Chlamydia trachomatis and Neisseria gonorrhea have been strongly associated with ectopic
pregnancy, infertility, and chronic pelvic pain. STDs during pregnancy might result in fetal death or
substantial physical and developmental disabilities, including mental retardation and blindness [70, 71]
• Hepatitis B. Vaccination is recommended for men and women who are at risk for acquiring hepatitis B
virus (HBV) infection. Preventing HBV infection in women of childbearing age prevents vertical
transmission of infection to infants and eliminates risk for infection and sequelae, including hepatic
failure, liver carcinoma, cirrhosis, and death [72–74]
participation in quality improvement projects (e.g., rapid
improvement cycles or collaborative groups). The feder-
ally funded Health Disparities Collaborative, the Perinatal
Care and Patient Safety Collaboratives, and similar quality
improvement efforts for community health centers demon-
strate how such approaches are being used to better serve
low-income and uninsured patients.
The need to develop innovative approaches to deliver
and ﬁnance bundles of preconception interventions must be
viewedasahighpriority.However,althoughstrongevidence
exists for many preconception care interventions and shows
they are effective, discussion continues regarding the bene-
ﬁts of delivering comprehensive preconception care [16, 80,
81], and the effectiveness or added value of “packaging”
or “bundling” these interventions remains to be determined.
For example, preconception care interventions could poten-
tially be bundled into behavioral modiﬁcation services (e.g.,
smoking and alcohol cessation, weight control, exercise),
screening and assessment (e.g., vaccines, general physical
examination), and specialized care (e.g., management of di-
abetes and hypertension). Alternatively, interventions could
be bundled into visits (e.g., do x at each well-woman visit,
do y every 2 years, do z only for women at risk). Some
evidence already suggests that bundling could be of added
value. For example, an evaluation of the National Centers of
Excellence in Women’s Health found that, compared with
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other settings, women received better-quality primary health
careatthosecentershavingbetterintegratedandcoordinated
services [82]. However, more such research, focused specif-
ically on integration of preconception care components into
primary care, is clearly warranted.
Efforts to promote healthy behavior and improve service
delivery should be accompanied by improvements in health
care coverage and ﬁnancing for women of childbearing age.
Affordability of care is a major concern for many women
[83], and more can be done to improve access to precon-
ception care. Many women under age 65 are uninsured, in-
cluding 40% of poor women, one third of near-poor women
(withincomebetween100%and200%ofthefederalpoverty
level), 50% of women with disabilities, and 29% of young
women ages 19–24 years [84]. Expanding health care cover-
age for low-income women, through public programs such
as Medicaid, Medicaid waivers, the State Children’s Health
Insurance Program (SCHIP), is particularly important. Med-
icaid offers particularly important opportunities. In 2003,
12% of all women of childbearing age (15–44 years) and
37% of poor women in that age group relied on Medicaid for
health care coverage [83]. Many low-income women do not,
however,qualifyforMedicaidbecausetheydonothavechil-
drenunderage18,arenotoverage65,orareundocumented.
As states seek to expand Medicaid coverage to low-income,
uninsured adults, women of childbearing age should receive
high priority.
Although two thirds of women in Medicaid are of
childbearing age [19–44, 85], many additional low-income
women do not qualify for Medicaid beneﬁts under current
state eligibility rules unless they are pregnant. Without cov-
erage before and between pregnancies, low-income women
typically miss preventive visits [83]. Recognizing these gaps
and missed opportunities for prevention, 21 states have de-
veloped special programs (under federal Medicaid waivers)
that cover some women who do not otherwise qualify for
Medicaid, particularly to offer family planning and intercon-
ception care. Speciﬁcally, these states extend eligibility to
womenwholosecoverageafterthebirthofababyorstarting
ajob,whileotherstatesofferfamilyplanningcoveragebased
onincomestatustomenand/orwomen[86].Anevaluationof
“family planning waiver” projects prepared for the federal
Center for Medicare and Medicaid Services (CMS) found
that they resulted in signiﬁcant savings to both the federal
and state governments [87]. Greater potential savings and
prevention, however, could undoubtedly result if states of-
fered more preconception risk screening, health promotion,
and interventions; to do so, however, states need permission
from the federal government to include such services in their
waiversorneedforCongresstoapproveinterconceptioncare
as an optional beneﬁt.
Finally, special attention should be given to the continu-
ing, and sometimes increasing, racial gap in poor outcomes,
especially in terms of access to services, and quality of care.
These priorities can potentially complicate decision-making
forpublichealthpolicy.Thebestevidenceofinterventionef-
fectiveness is often based on studies of health care systems.
However, in developing programs and policies for the de-
livery of preconception services, one must consider the fact
that poor access to health care can be a major determinant of
health disparities.
Preconception care: the next maternal and child
health frontier
The signiﬁcant improvements in infant and maternal preg-
nancyoutcomesduringthepast40yearshaveresultedlargely
from the intensiﬁed focus on family planning in the 1960s
and 1970s, on child health in the 1970s and 1980s, and on
prenatal care in the 1980s and 1990s. Over the past 40 years,
manypublichealthandclinicalcareprovidersandtheirorga-
nizations have also recognized that, although it is important
to offer family planning services to prevent unplanned preg-
nancies, it is not enough to worry about a pregnant woman’s
health only during her pregnancy or a child’s health only
after its birth, because many of the factors that contribute to
the mother’s and child’s health can be identiﬁed and often
successfully managed before pregnancy.
Today, the greatest opportunities for further improvement
in pregnancy outcomes—in improving the health of women
and their children—lie in prevention strategies that must be
implemented prior to conception to be effective. In 1989,
the U.S. Public Health Service Expert Panel identiﬁed pre-
conception care as an essential part of prenatal care [88].
National organizations of health professionals, such as the
AAP, ACOG, and the American Academy of Family Physi-
cians (AAFP), all recommend speciﬁc components of pre-
conception care that should be delivered within the context
of health care systems [15, 89]. The time has come to move
forward to the next maternal and child health frontier of
“prevention” by acting on the recommendations of profes-
sional organizations and implementing scientiﬁcally proven
interventions to further improve pregnancy outcomes.
Action is urgently required in an array of clinical settings,
inhealthpromotioncampaigns,andinacademicresearchset-
tings. Because of the wide range of interventions included
under the umbrella of preconception care, such interven-
tions may be delivered in both primary care and specialty
care practices. However, opportunities also exist to improve
preconception health through wellness care, through main-
tenance care for women with chronic health conditions asso-
ciated with increased preconception risk (e.g., maternal di-
abetes), and in settings where women seek medical support
for one speciﬁc risk such as smoking or obesity. In addi-
tion, more research is needed to understand how a women’s
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motivation for healthy behavior can be used to initiate the
reduction of a number of preconception risks. For example,
comparisonofconcurrentversussequentialinterventionsfor
smoking and weight control requires additional clariﬁcation
[90].
Above all, health care providers and health agencies must
understand that early prenatal care is too late for many
women and babies. In particular, some evidence-based in-
terventions recommended for implementation during preg-
nancy could be more effective and beneﬁcial if implemented
before conception. For example, although smoking cessa-
tion is recommended for all pregnant women, more than one
attempt to stop may be necessary to achieve success. Only
about 20% of pregnant women who smoke are able to stop
smoking during pregnancy [90]. Starting smoking cessation
treatment — and successfully completing it—should be rec-
ommended before pregnancy is begun. Similarly, the only
deﬁnitive way of preventing fetal alcohol syndrome is to
stop drinking even before pregnancy. In the same manner,
HIV testing and genetic counseling are recommended dur-
ing pregnancy, but additional options are available to women
who use these interventions prior to conception, including
the decision not to become pregnant.
Conclusion
There is ample evidence that individual elements of pre-
conception care work. Equally important, however, is the
evidence that some interventions work best and others only
work if provided before pregnancy. Given these realities, to
further improve perinatal outcomes, the United States must
commit to improving preconception health and to providing
preconception care to all women of reproductive age. Even
though sufﬁcient knowledge and evidence is present to take
action now, further efforts are needed to identify best prac-
tices and the most effective means of delivering integrated
preconception services.
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